A randomized, open-label, phase III trial of pertuzumab retreatment in HER2-positive locally advanced/metastatic Breast cancer patients previously treated with pertuzumab, trastuzumab and chemotherapy: The Japan Breast cancer research group-M05 PRECIOUS study

Yutaka Yamamoto, Hiroji Iwata, Takayuki Ueno, Naruto Taira, Masahiro Kashiwaba, Masato Takahashi, Hiroshi Tada, Koichiro Tsugawa, Tatsuya Toyama, Naoki Niikura, Fumikata Hara, Tomomi Fujisawa, Tetsuhiro Yoshinami, Shigehira Saji, Toshimi Takano, Norikazu Masuda, Satoshi Morita, Masakazu Toi, Shinji Ohno

Research output: Contribution to journalArticlepeer-review

3 Citations (Scopus)

Fingerprint

Dive into the research topics of 'A randomized, open-label, phase III trial of pertuzumab retreatment in HER2-positive locally advanced/metastatic Breast cancer patients previously treated with pertuzumab, trastuzumab and chemotherapy: The Japan Breast cancer research group-M05 PRECIOUS study'. Together they form a unique fingerprint.

Medicine & Life Sciences